Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Osteoporosis is the most common chronic metabolic bone disease. It has been estimated that more than 10 million people in the United States and 200 million men and women worldwide have osteoporosis. Given that the aging population is rapidly increasing in many countries, osteoporosis could become a...
Main Authors: | Ji-Yoon Noh, Young Yang, Haiyoung Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7623 |
Similar Items
-
Osteoporosis: From Molecular Mechanisms to Therapies 2.0
by: Chih-Hsin Tang
Published: (2020-10-01) -
Osteoporosis: From Molecular Mechanisms to Therapies 3.0
by: Chih-Hsin Tang
Published: (2021-11-01) -
Expert suggestion for osteoporosis management during the recent COVID-19 pandemic
by: Chinese Society of Endocrinology,Chinese Medical Association , et al
Published: (2022-04-01) -
Eleven years secular trend of the initiation of anti-osteoporosis medications and subsequent fractures in Taiwan: From 2008 to 2018
by: Tsung-Han Yang, et al.
Published: (2023-01-01) -
Editorial: Molecular mechanisms of osteoporosis
by: Ziqing Li, et al.
Published: (2023-10-01)